Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Frontier Ip (FIPP) Share Price

Price 20.00p on 12-11-2025 at 12:35:10
Change -1.00p -4.76%
Buy 22.00p
Sell 20.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 20,340.00 at 21.34999p
Day's Volume: 46,176
Last Close: 21.00p
Open: 21.00p
ISIN: GB00B63PS212
Day's Range 20.00p - 20.00p
52wk Range: 16.50p - 30.50p
Market Capitalisation: £13.78m
VWAP: 20.7023p
Shares in Issue: 68.90m

Sector: Industrial Services

Listed In: FTSE AIM All-Share,

Frontier Ip (FIPP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 20,340 21.34999p Ordinary
 11:51:06 - 12-Nov-25
Sell* 1,000 20.02p Ordinary
 11:34:59 - 12-Nov-25
Sell* 44 20.02p Ordinary
 11:01:53 - 12-Nov-25
Sell* 44 20.00p Uncrossing Trade
 11:00:15 - 12-Nov-25
Sell* 24,748 20.20p Ordinary
 09:55:36 - 12-Nov-25
Buy* 23,194 21.54p Ordinary
 11:42:18 - 11-Nov-25
Sell* 20,568 20.221p Ordinary
 10:17:38 - 11-Nov-25
Buy* 450 22.00p SI Trade
 09:15:11 - 11-Nov-25
Buy* 5 22.00p SI Trade
 09:15:11 - 11-Nov-25
Buy* 15 22.00p SI Trade
 09:15:11 - 11-Nov-25
See more Frontier Ip trades

Frontier Ip (FIPP) Share Price History

Time period:
to
Date Open High Low Close Volume
12th Nov 2025 (Wed) 21.00 20.00 20.00 21.00 46,176
11th Nov 2025 (Tue) 21.00 21.00 21.00 21.00 44,732
10th Nov 2025 (Mon) 21.00 21.00 21.00 21.00 35,264
7th Nov 2025 (Fri) 21.00 21.00 21.00 21.00 9,421
6th Nov 2025 (Thu) 22.00 22.00 21.00 21.00 143,239
5th Nov 2025 (Wed) 24.00 24.00 22.00 22.00 250,146
4th Nov 2025 (Tue) 24.00 24.00 24.00 24.00 98,129
3rd Nov 2025 (Mon) 23.50 25.50 23.50 24.00 234,647
31st Oct 2025 (Fri) 23.50 23.50 23.50 23.50 3,911
30th Oct 2025 (Thu) 23.50 23.50 23.50 23.50 228,429
29th Oct 2025 (Wed) 24.00 24.00 23.50 23.50 90,581
28th Oct 2025 (Tue) 24.50 24.50 24.00 24.00 198,656
27th Oct 2025 (Mon) 22.00 24.50 23.50 24.50 491,878
24th Oct 2025 (Fri) 19.50 22.00 19.50 22.00 297,838
23rd Oct 2025 (Thu) 19.00 19.50 19.10 19.10 64,991
22nd Oct 2025 (Wed) 19.00 19.00 19.00 19.00 1,854
21st Oct 2025 (Tue) 19.00 19.00 19.00 19.00 105,047
20th Oct 2025 (Mon) 19.00 19.00 19.00 19.00 48,449
17th Oct 2025 (Fri) 18.50 18.50 18.50 18.50 60,383
16th Oct 2025 (Thu) 18.00 18.50 18.00 18.50 298,953
15th Oct 2025 (Wed) 18.00 18.00 17.50 18.00 133,652
14th Oct 2025 (Tue) 17.80 17.80 17.00 17.50 66,689
13th Oct 2025 (Mon) 17.00 17.50 17.00 17.00 94,538
See more Frontier Ip price history

Frontier Ip (FIPP) Regulatory News

Date Source Headline
6th Nov 2025 7:00 am RNS Bord Change
3rd Nov 2025 7:00 am RNS-R TVG demonstrates success in animal trials
20th Oct 2025 7:00 am RNS-R Amprologix raises £740,000 in Pre-Series A round
25th Sep 2025 7:00 am RNS Board Changes
24th Sep 2025 5:12 pm RNS Holding(s) in Company
13th Jun 2025 7:00 am RNS Strategic partnership for Cambridge innovation hub
10th Jun 2025 7:00 am RNS-R Alusid signs international distribution agreement
6th May 2025 7:00 am RNS-R TVG's vaccine candidate enters animal trials
16th Apr 2025 7:00 am RNS-R Syva signs option to license agreement with TVG
2nd Apr 2025 4:47 pm RNS Director/PDMR Shareholding
See more Frontier Ip regulatory news

Frontier Ip (FIPP) Share News

CORRECT: SSP chair to depart; Hays CEO goes on medical leave

10th Nov 2025 11:19

(Correcting that the announcements were made both on Monday and in the the past week.) Read More

EXECUTIVE CHANGES: SSP chair to depart; Hays CEO goes on medical leave

10th Nov 2025 10:34

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More

Frontier IP's Vaccine Group reports strong cattle trial results

3rd Nov 2025 12:55

(Alliance News) - Frontier IP Group PLC on Monday said its portfolio company Vaccine Group Ltd has achieved "outstanding" results in animal trials for two vaccine candidates targeting bovine respiratory syncytial virus (BRSV), a major livestock disease. Read More

IN BRIEF: Frontier IP celebrates Amprologix fundraise

20th Oct 2025 12:21

Frontier IP Group PLC - London-based intellectual property commercialisation firm - Portfolio company Amprologix raises GBP740,000 to accelerate development of its novel antibiotics for antimicrobial-resistant diseases. Funds will go towards completion of the pre-clinical development of lead candidate epidermicin NI01, which is being developed to treat Methicillin-resistant Staphylococcus aureus, MRSA. Expects phase 1 human clinical trials to start next year. Says Amprologix is also preparing for a Series A funding round. Investors in the recent fundraise included individuals and "angel-investor network" Plutus Investment Group LLP. Plutus' Venture Partner Rita Dobmeyer will be joining Amprologix's board as a non-executive director to support clinical development. Frontier says Amprologix is also in the early stages of developing an antibiotic to treat and prevent Clostridioides difficile or C difficile infections. Read More

EXECUTIVE CHANGES: STV names Mothercare's Clive Whiley as next chair

26th Sep 2025 08:53

(Alliance News) - The following is a round-up of directorate changes announced by London-listed companies this week and not separately reported by Alliance News: Read More

See more Frontier Ip news
FTSE 100 Latest
Value9,903.32
Change3.72

Login to your account

Forgot Password?

Not Registered